Evidence of the performance of physiotherapy in covid19 in the emergency room: an integrative review
International Journal of Development Research
Evidence of the performance of physiotherapy in covid19 in the emergency room: an integrative review
Received 27th February, 2022; Received in revised form 22nd March, 2022; Accepted 19th April, 2022; Published online 20th May, 2022
Copyright © 2022, Thamires do Nascimento Silva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The first records of the Severe Acute Respiratory Syndrome Virus (SARS-COV-2), known worldwide as Covid-19 occurred in the city of Wuhan, China, in December 2018 and in February 2020 the first case was registered in Brazil, in the city from Sao Paulo. On March 11, 2020, WHO characterized Covid-19 as a pandemic, due to its rapid proliferation throughout the world and its high transmissibility, and currently has a high number of deaths. Covid-19 is a disease that can cause acute respiratory infection, transmitted by the coronavirus, which is a beta-coronavirus, and has recently been called SARS-CoV-2. The aim of this integrative review was to carry out an expanded search in the national and international literature on the role of physical therapy at Covid 19 in urgency and emergency units. This study is an integrative review, integration of opinions, analysis of decision-making, whose method pays attention to the evidence-based health focus. Publications indexed in the Scopus, Medline Pubmed and Web Of Science databases were searched and we used Covid-19, emergency department and physiotherapy as descriptors. The study exclusion criteria were: abstracts, theses, dissertations, opinion articles, comments, course conclusion work (TCC), experience reports and conference proceedings. A total of 1620 studies were identified, of which 4 studies were included. With the entry of more critically ill patients, confirmed with thoracic image changes suggestive of Covid-19, there was an indication for the use of low or high flow oxygen and the suggestion for the use of invasive mechanical ventilation (IMV) or not (NIV) in these environments and also in the intensive care unit (ICU). However, the use of NIV in routine use was not recommended, as the current experience with Covid's 19 hypoxemic respiratory failure had a high associated failure rate. It is suggested that the topic be expanded with the presentation of more robust studies, which generate an impact on the scientific community and better conduct of treatment during the acute phase of the disease.
